| Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers A Filipowicz, S Wołowiec International journal of pharmaceutics 408 (1-2), 152-156, 2011 | 92 | 2011 |
| Biotinylated PAMAM G3 dendrimer conjugated with celecoxib and/or Fmoc-l-Leucine and its cytotoxicity for normal and cancer human cell lines Ł Uram, A Filipowicz, M Misiorek, N Pieńkowska, J Markowicz, ... European Journal of Pharmaceutical Sciences 124, 1-9, 2018 | 36 | 2018 |
| Cellular uptake of glucoheptoamidated poly (amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs Ł Uram, M Szuster, A Filipowicz, M Zaręba, E Wałajtys-Rode, S Wołowiec Bioorganic & Medicinal Chemistry 25 (2), 706-713, 2017 | 36 | 2017 |
| In vitro cytotoxicity of the ternary PaMaM g3–pyridoxal–biotin bioconjugate Ł Uram, M Szuster, K Gargasz, A Filipowicz, E Wałajtys-Rode, ... International journal of nanomedicine, 4707-4720, 2013 | 20 | 2013 |
| Different patterns of nuclear and mitochondrial penetration by the G3 PAMAM dendrimer and its biotin–pyridoxal bioconjugate BC-PAMAM in normal and cancer cells in vitro Ł Uram, M Szuster, A Filipowicz, K Gargasz, S Wołowiec, ... International journal of nanomedicine, 5647-5661, 2015 | 19 | 2015 |
| Bioconjugates of PAMAM dendrimers with trans-retinal, pyridoxal, and pyridoxal phosphate A Filipowicz, S Wołowiec International Journal of Nanomedicine, 4819-4828, 2012 | 19 | 2012 |
| The effect of G3 PAMAM dendrimer conjugated with B-group vitamins on cell morphology, motility and ATP level in normal and cancer cells Ł Uram, M Szuster, M Misiorek, A Filipowicz, S Wołowiec, ... European Journal of Pharmaceutical Sciences 102, 275-283, 2017 | 15 | 2017 |
